INTELLIGENCE IN ACTION

HIMSS19 Showed Glimpses of a Bright Future, But Also Problem Solving in the Here and Now

March 25, 2019

Dr. Andrew Mellin, Surescripts VP of Medical Informatics Physician has been to nearly 20 HIMSS conferences over his career, wearing different hats as a physician, as a vendor and as a health system leader. But this one, his first one as a member of the Surescripts team, felt different, as he explained in a recent article on LinkedIn.

“With my many conversations with provider leaders, technology companies, healthcare associations, and entrepreneurs—I felt like I was at the center of something big and impactful, [as Surescripts] is a facilitator that brings together virtually every major stakeholder in healthcare, including arch competitors, with a common goal to improve safety, lower costs and ensure quality care,” says Dr. Mellin.

“To me, the most profound impact the Surescripts Network Alliance will have in the next few years is removing the opaque reality of an individual person’s financial responsibility for a prescription,” he says.

Dr. Mellin had the opportunity to facilitate a panel at the HIMSS Interoperability Showcase, with a focus on the need for, and transformative power of, prescription price transparency at the point of care. The panelists, all participants in the Network Alliance, talked frankly about the very real need for this technology and that it can be a real game changer in the care journey. Not just for the patient, but for the prescriber, as well, which can help alleviate the very real phenomenon of physician burnout, noted a number of the panelists.

“This HIMSS was different for me—it was not about cool technologies and future promises, but it was about solving difficult, industry-wide problems today. The rapid adoption and value realization for prescription price transparency tools is the manifestation of years of work by my colleagues and people across the industry to build a foundation of trust, technology, and standards,” Dr. Mellin says. “And, I’m excited to work across the industry to put this tool in every provider’s hands and to work with the Surescripts Network Alliance to solve the next hard challenge.”

To read Dr. Mellin’s full take on HIMSS19, check out his article on LinkedIn. And for more on Surescripts’ experience at HIMSS19, be sure to view our highlights video

Related Articles

August 13, 2019

When Paperwork Comes Before Patients: Missing Key Information Complicates Specialty Prescribing

William J. Mayo, MD, (“Doctor Will”) said, “The best interest of the patient is the only interest to be considered, and in order that the sick may have the benefit of advancing knowledge, union of forces is necessary.”

Read more...
July 25, 2019

How Aurora Health Care Used Electronic Prior Authorization To Cut Clinic Staff Overtime By More Than Half

The reality of traditional prior authorization is this: While the prescriber, the PBM and the pharmacy team spend valuable time making phone calls, tracking down information and filling out forms, the patient waits. And waits. And waits. In other words, patients face delays in receiving their prescriptions, clinicians lose valuable time and the health system faces mounting overtime costs.

Read more...
July 22, 2019

The Onerous Specialty Prescribing Process Hurts Patients and Tires Doctors. What Can Be Done?

It really should be so simple—getting a patient on a specialty therapy. The doctor and patient have chosen the best therapy; the patient is in great need. But according to our recent survey of 500 prescribers, on average it can take nearly 8 days to start patients on specialty medications, which are used to treat challenging chronic conditions such as cancer, multiple sclerosis and rheumatoid arthritis. 

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX